# Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer

> **NCT00212095** · PHASE2 · COMPLETED · sponsor: **National University Hospital, Singapore** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** docetaxel and ketoconazole

## Key facts

- **NCT ID:** NCT00212095
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-04
- **Final completion:** 2012-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212095, "Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00212095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*